Abstract
Sulfation is an important component of the body’s chemical defence mechanism, and provides a major route for the metabolism, detoxification and elimination of a host of xenobiotics (Coughtrie 1996). In addition to this role, sulfation also functions in the homeostasis of a number of important endogenous compounds, including iodothyronines (Visser 1996), steroid hormones (Roy 1992), oxysterols (Javitt et al. 2001) and catecholamines (Goldstein et al. 1999). These reactions are catalysed by members of the sulfotransferase (SULT) enzyme superfamily that transfer a sulfuryl moiety from the co-substrate 3′-phopshoadenosine 5′-phosphosulfate (PAPS). In humans, the SULT family numbers at least 11 members derived from at least 10 genes. The human SULTs can be subdivided into 3 different subfamilies based on amino acid sequence similarity and functional activity, and the largest family, SULT1 or phenol SULT, currently comprises 7 members (Coughtrie et al. 2001). Humans (and other primates) differ from most animal species in that they have significant levels of circulating catecholamine sulfates; for example up to 98% of circulating dopamine is in its sulfated form (Goldstein et al. 1999). It is believed that the gastrointestinal tract is the major source of these circulating catecholamine sulfates (Goldstein et al. 1999), and indeed significant increases in plasma dopamine sulfate can be observed after ingestion of bananas (Davidson et al. 1981) which are rich in dopamine (Kanazawa et al. 2000).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bidwell L. M., McManus M. E., Gaedigk A., Kakuta Y. et al., 1999, Crystal structure of human catecholamine sulfotransferase. J Mol Biol, 293: 521–530.
Brix L. A., Duggleby R. G., Gaedigk A., and McManus M. E., 1999, Structural characterization of human aryl sulphotransferases. Biochem J, 337: 337–343.
Coughtrie M. W. H., 1996, Sulphation catalysed by the human cytosolic sulphotransferases — chemical defence or molecular terrorism? Hum Exp Toxicol, 15: 547–555.
Coughtrie M. W. H., and Johnston L. E., 2001, Interactions between dietary chemicals and human sulfotransferases — Molecular mechanisms and clinical significance. Drug Metab Dispos, 29: 522–528.
Dajani R., Cleasby A., Neu M., Wonacott A. J. et ai, 1999, X-ray crystal structure of human dopamine sulfotransferase, SULT1A3: Molecular modelling and QSAR analysis demonstrate a molecular basis for sulfotransferase substrate specificity. J Biol Chem, 274: 37862–37868.
Dajani R., Hood A. M., and Coughtrie M. W. H., 1998, A single amino acid, Glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3. Mol Pharmacol, 54: 942–948.
Davidson L., Vandongen R., and Beilin L. J., 1981, Effect of eating bananas on plasma free and sulfate-conjugated catecholamines. Life Sci., 29: 1773–1778.
Dooley T. P., 1998, Molecular biology of the human phenol sulfotransferase gene family. Journal Of Experimental Zoology, 282: 223–230.
Goldstein D. S., Swoboda K. J., Miles J. M., Coppack S. W. et ai, 1999, Sources and physiological significance of plasma dopamine sulfate. J Clin Endocrinol Metab, 84: 2523–2531.
Javitt N. B., Lee Y. C., Shimizu C., Fuda H. et al., 2001, Cholesterol and hydroxycholesterol sulfotransferases: Identification, distinction from dehydroepiandrosterone sulfotransferase, and differential tissue expression. Endocrinology, 142: 2978–2984.
Kakuta Y., Pedersen L. G., Carter C. W., Negishi M. et ai, 1997, Crystal structure of estrogen sulphotransferase. Nature Struct Biol, 4: 904–908.
Kakuta Y., Petrotchenko E. V., Pedersen L. C., and Negishi M., 1998, The sulfuryl transfer mechanism: crystal structure of a vanadate complex of estrogen sulfotransferase and mutational analysis. J Biol Chem, 273: 27325–27330.
Kanazawa K., and Sakakibara H., 2000, High content of dopamine, a strong antioxidant, in Cavendish banana. J Agr Food Chem, 48: 844–848.
Rein G., Glover V., and Sandler M., 1982, Mutiple forms of phenolsulphotransferase in human tissues. Selective inhibition by dichloronitrophenol. Biochem Pharmacol, 31: 1893–1897.
Richard K., Hume R., Kaptein E., Stanley E. L. et ai, 2001, Sulfation of thyroid hormone and dopamine during human development — ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung and brain. J Clin Endocrinol Metab, 86: 2734–2742.
Roy A. K., 1992, Regulation of steroid hormone action in target cells by specific hormone-inactivating enzymes. Proc Soc Exp Biol Med, 199: 265–272.
Rubin G. L., Sharp S., Jones A. L., Glatt H. et ai, 1996, Design, production and characterisation of antibodies discriminating between the phenol- and monoamine-sulphating forms of human phenol sulphotransferase. Xenobiotica, 26: 1113–1119.
Visser T. J., 1996, Pathways of thyroid hormone metabolism. Acta Med Austriaca, 1/2: 10–16.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Coughtrie, M.W.H., Taskinen, J., Hood, A.M. (2002). Molecular Basis for the Substrate Specificity of Human Catecholamine Sulfotransferase, SULT1A3. In: Nagatsu, T., Nabeshima, T., McCarty, R., Goldstein, D.S. (eds) Catecholamine Research. Advances in Behavioral Biology, vol 53. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3538-3_34
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3538-3_34
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3388-1
Online ISBN: 978-1-4757-3538-3
eBook Packages: Springer Book Archive